• MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Lipid Panel
  • Mu-opioid receptor 1 (OPRM1) Genotyping
  • Small Nuclear Ribonucleoprotein Polypeptide N and Ubiquitin Protein Ligase E3A (SNRPN/UBE3A) Methylation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Additional ICD10
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.